Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Bodey

Showing results (81-90 of 726) with videos related to

Pageof 73
Sort By:
The Journal of Antibiotics|February 1, 1976
Comparative in vitro activity of cephalosporinsD Stewart, G P Bodey
Medical and Pediatric Oncology|January 1, 1981
Protected environments in cancer chemotherapy: design and function of a large unitG P Bodey, B Rosenbaum
Current Therapeutic Research, Clinical and Experimental|May 1, 1973
Evaluation of a bacteriostatic soap, P-300, on skin flora of patients in protected environmentsG P Bodey, B Rosenbaum
The Journal of Antibiotics|July 1, 1974
In vitro activity of BL-S217, a new cephalosporin antibioticF Casey, G P Bodey
Antimicrobial Agents and Chemotherapy|May 1, 1977
Azlocillin: in vitro studies of a new semisynthetic penicillinD Stewart, G P Bodey
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1989
AspergillosisG P Bodey, S Vartivarian
Applied Microbiology|April 1, 1971
In vitro studies of semisynthetic alpha-(substituted-ureido) penicillinsG P Bodey, D Stewart
Applied Microbiology|January 1, 1971
In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillinG P Bodey, B Deerhake
Medicine|May 1, 1974
Effect of prophylactic measures on the microbial flora of patients in protected environment unitsG P Bodey, B Rosenbaum
Current Therapeutic Research, Clinical and Experimental|June 1, 1970
Preliminary studies of 6-(D-alpha-sulfoaminophenylacetamido) penicillanic acid (BL-P1462) in the treatment of Pseudomonas infectionsG P Bodey, V Rodriguez
Pageof 73

Showing results (81-90 of 726) with videos related to

Sort By:
Pageof 73
The Journal of Antibiotics|February 1, 1976
Comparative in vitro activity of cephalosporinsD Stewart, G P Bodey
Medical and Pediatric Oncology|January 1, 1981
Protected environments in cancer chemotherapy: design and function of a large unitG P Bodey, B Rosenbaum
Current Therapeutic Research, Clinical and Experimental|May 1, 1973
Evaluation of a bacteriostatic soap, P-300, on skin flora of patients in protected environmentsG P Bodey, B Rosenbaum
The Journal of Antibiotics|July 1, 1974
In vitro activity of BL-S217, a new cephalosporin antibioticF Casey, G P Bodey
Antimicrobial Agents and Chemotherapy|May 1, 1977
Azlocillin: in vitro studies of a new semisynthetic penicillinD Stewart, G P Bodey
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 1, 1989
AspergillosisG P Bodey, S Vartivarian
Applied Microbiology|April 1, 1971
In vitro studies of semisynthetic alpha-(substituted-ureido) penicillinsG P Bodey, D Stewart
Applied Microbiology|January 1, 1971
In vitro studies of alpha-carboxyl-3-thienylmethyl penicillin, a new semisynthetic penicillinG P Bodey, B Deerhake
Medicine|May 1, 1974
Effect of prophylactic measures on the microbial flora of patients in protected environment unitsG P Bodey, B Rosenbaum
Current Therapeutic Research, Clinical and Experimental|June 1, 1970
Preliminary studies of 6-(D-alpha-sulfoaminophenylacetamido) penicillanic acid (BL-P1462) in the treatment of Pseudomonas infectionsG P Bodey, V Rodriguez
Pageof 73